Activation of the Prostaglandin E2 receptor EP2 prevents house dust mite‐induced airway hyperresponsiveness and inflammation by restraining mast cells’ activity

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical and Experimental Allergy

• Publication date

  2015-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cea.12542PMID 25823713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The PGE2-EP2-mast cell axis: an antiasthma mechanism.

  2015cited by this paper
• Prostaglandin E₂ suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells.

  2014cited by this paper
• Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE‐dependent secretion from human lung mast cells

  2013cited by this paper
• Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin‐intolerant asthmatics

  2013cited by this paper
• Cyclooxygenase-2 inhibits T helper cell type 9 differentiation during allergic lung inflammation via down-regulation of IL-17RB.

  2013cited by this paper
• Locally administered prostaglandin E2 prevents aeroallergen-induced airway sensitization in mice through immunomodulatory mechanisms.

  2013cited by this paper
• Regulation of Immune Responses by Prostaglandin E2

  2012cited by this paper
• Prostaglandin E2 Produced by the Lung Augments the Effector Phase of Allergic Inflammation

  2012cited by this paper
• Severe asthma: advances in current management and future therapy.

  2012cited by this paper
• Asthma phenotypes: the evolution from clinical to molecular approaches

  2012cited by this paper
• E‐prostanoid 2 receptors dampen mast cell degranulation via cAMP/PKA‐mediated suppression of IgE‐dependent signaling

  2012cited by this paper
• Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma.

  2011cited by this paper
• Chronic allergen challenge induces bronchial mast cell accumulation in BALB/c but not C57BL/6 mice and is independent of IL-9

  2010cited by this paper
• [A cyclooxygenase-2 selective inhibitor worsens respiratory function and enhances mast cell activity in ovalbumin-sensitized mice].

  2009cited by this paper
• Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2

  2009cited by this paper
• Innate cells and T helper 2 cell immunity in airway inflammation.

  2009cited by this paper
• Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production

  2009cited by this paper
• Un inhibidor selectivo de la ciclooxigenasa-2 empeora la función respiratoria y fomenta la actividad de los mastocitos en ratones sensibilizados a la ovalbúmina

  2009cited by this paper
• Subcutaneous Prostaglandin E2 Restrains Airway Mast Cell Activity in vivo and Reduces Lung Eosinophilia and Th2 Cytokine Overproduction in House Dust Mite-Sensitive Mice

  2009cited by this paper
• Airway Inflammation

  2009cited by this paper
• Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration

  2008cited by this paper
• Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors1

  2008cited by this paper
• Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice.

  2007cited by this paper
• Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent.

  2006cited by this paper
• Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses.

  2006cited by this paper
• Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation

  2006cited by this paper
• Augmentation of allergic inflammation in the airways of cyclooxygenase‐2‐deficient mice

  2005cited by this paper
• Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3

  2005cited by this paper
• Evaluation of Selective Prostaglandin E2 (PGE2) Receptor Agonists as Therapeutic Agents for the Treatment of Asthma

  2005cited by this paper
• Stimulation of protease‐activated receptor‐2 inhibits airway eosinophilia, hyperresponsiveness and bronchoconstriction in a murine model of allergic inflammation

  2005cited by this paper
• Cyclooxygenase Inhibition Augments Allergic Inflammation through CD4-Dependent, STAT6-Independent Mechanisms1

  2005cited by this paper
• Allergen-Induced Airway Hyperresponsiveness Mediated by Cyclooxygenase Inhibition Is Not Dependent on 5-Lipoxygenase or IL-5, but Is IL-13 Dependent1

  2005cited by this paper
• Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM‐CSF

  2004cited by this paper
• The lung as a privileged site for the beneficial actions of PGE2.

  2004cited by this paper
• Intranasal Exposure of Mice to House Dust Mite Elicits Allergic Airway Inflammation via a GM-CSF-Mediated Mechanism1

  2004cited by this paper
• Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism

  2003cited by this paper
• Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma.

  2003cited by this paper
• Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice.

  2002cited by this paper
• FunctionsIL-10, Which Down-Regulates Dendritic Cell Enhances the Production of Endogenous 2 Cyclooxygenase-2-Issued Prostaglandin E

  2002cited by this paper
• Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation.

  1999cited by this paper
• Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics.

  1999cited by this paper
• Noninvasive system for evaluating the allergen-specific airway response in a murine model of asthma.

  1999cited by this paper
• Allergic lung responses are increased in prostaglandin H synthase-deficient mice.

  1999cited by this paper
• Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography.

  1997cited by this paper
• Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.

  1996cited by this paper
• Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects.

  1994cited by this paper
• Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene.

  1993cited by this paper
• Regulation of human alveolar macrophage- and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone.

  1992cited by this paper
• 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells.

  1987cited by this paper
• The mast cell as a primary effector cell in the pathogenesis of asthma.

  1986cited by this paper
• Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization.

  1980cited by this paper

• A helminth enzyme subverts macrophage-mediated immunity by epigenetic targeting of prostaglandin synthesis.

  2024cites this paper
• Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate subgroup.

  2024cites this paper
• Fluoxetine restrains allergic inflammation by targeting an FcɛRI-ATP positive feedback loop in mast cells

  2023cites this paper
• Differential protease content of mast cells and the processing of IL-33 in Alternaria alternata induced allergic airway inflammation in mice

  2023cites this paper
• The role of PGE2 and EP receptors on lung's immune and structural cells; possibilities for future asthma therapy.

  2022cites this paper
• Eating increases and exercise decreases disease activity in patients with symptomatic dermographism.

  2022cites this paper
• Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections

  2021cites this paper
• Eicosanoid receptors as therapeutic targets for asthma.

  2021cites this paper
• Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma

  2021cites this paper
• Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids

  2021cites this paper
• Caspase-11 promotes allergic airway inflammation

  2020cites this paper
• Mast Cells and Nanomaterials

  2020cites this paper
• In Vitro and In Vivo Validation of EP2-Receptor Agonism to Selectively Achieve Inhibition of Mast Cell Activity

  2020cites this paper
• PGE2 deficiency predisposes to anaphylaxis by causing mast cell hyper-responsiveness.

  2020cites this paper
• Mouse Strain-Dependent Difference Toward the Staphylococcus aureus Allergen Serine Protease-Like Protein D Reveals a Novel Regulator of IL-33

  2020cites this paper
• Selenium and selenoproteins in prostanoid metabolism and immunity

  2019cites this paper
• Cyclooxygenase-1 Regulates the Development of Follicular Th Cells via Prostaglandin E2

  2019cites this paper
• FLUOXETINE ATTENUATES MAST CELL FUNCTION BY TARGETING PURINERGIC SIGNALING

  2019cites this paper
• Prostaglandins in asthma and allergic diseases☆

  2019cites this paper
• Development and validation of the mastocytosis activity score

  2018cites this paper
• Mast cell-dependent IL-33/ST2 signaling is protective against the development of airway hyperresponsiveness in a house dust mite mouse model of asthma.

  2018cites this paper
• Non-asthmatic eosinophilic bronchitis and its relationship with asthma.

  2017cites this paper
• Targeting the IL-33/ST2 pathway in asthma : implications for development, exacerbation and treatment

  2017influential citation
• Potential functional and pathological side effects related to off-target pharmacological activity.

  2017cites this paper
• Cyclooxygenase 2: its regulation, role and impact in airway inflammation

  2016cites this paper
• PGE2‐treated macrophages inhibit development of allergic lung inflammation in mice

  2016cites this paper
• Specific immunotherapy generates CD8+ CD196+ T cells to suppress lung cancer growth in mice

  2016cites this paper
• Development and validation of the mastocytosis quality of life questionnaire: MC‐QoL

  2016cites this paper
• Efeitos da MT-I, uma fosfolipase A2, isolada do veneno de Bothrops asper em mastócitos: ativação e sinalização intracelular envolvida na desgranulação.

  2015cites this paper